Levin Capital Strategies’s BioAmber Inc. BIOA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-11,200
| Closed | – | – | 230 |
|
|
2019
Q1 | $0 | Hold |
11,200
| – | – | ﹤0.01% | 282 |
|
|
2018
Q4 | $0 | Hold |
11,200
| – | – | ﹤0.01% | 326 |
|
|
2018
Q3 | $0 | Hold |
11,200
| – | – | ﹤0.01% | 329 |
|
|
2018
Q2 | $1K | Sell |
11,200
-5,600
| -33% | -$500 | ﹤0.01% | 292 |
|
|
2018
Q1 | $1K | Hold |
16,800
| – | – | ﹤0.01% | 309 |
|
|
2017
Q4 | $7K | Sell |
16,800
-125,808
| -88% | -$59.8K | ﹤0.01% | 307 |
|
|
2017
Q3 | $70K | Sell |
142,608
-63,994
| -31% | -$76.4K | ﹤0.01% | 331 |
|
|
2017
Q2 | $531K | Buy |
206,602
+24,550
| +13% | +$56.4K | 0.01% | 191 |
|
|
2017
Q1 | $422K | Buy |
182,052
+19,312
| +12% | +$73.4K | 0.01% | 214 |
|
|
2016
Q4 | $895K | Sell |
162,740
-3,067
| -2% | -$14.7K | 0.02% | 169 |
|
|
2016
Q3 | $703 | Sell |
165,807
-25,870
| -13% | -$95.6K | 0.01% | 203 |
|
|
2016
Q2 | $571K | Buy |
191,677
+3,344
| +2% | +$12.2K | 0.01% | 212 |
|
|
2016
Q1 | $791K | Hold |
188,333
| – | – | 0.01% | 190 |
|
|
2015
Q4 | $1.16M | Buy |
188,333
+83,754
| +80% | +$631K | 0.02% | 188 |
|
|
2015
Q3 | $559K | Hold |
104,579
| – | – | 0.01% | 240 |
|
|
2015
Q2 | $899K | Sell |
104,579
-144,079
| -58% | -$1.32M | 0.01% | 216 |
|
|
2015
Q1 | $2.17M | Sell |
248,658
-53,027
| -18% | -$466K | 0.03% | 165 |
|
|
2014
Q4 | $2.53M | Sell |
301,685
-8,447
| -3% | -$76.9K | 0.04% | 162 |
|
|
2014
Q3 | $3.1M | Buy |
310,132
+37,100
| +14% | +$434K | 0.05% | 155 |
|
|
2014
Q2 | $2.72M | Sell |
273,032
-41,170
| -13% | -$425K | 0.04% | 166 |
|
|
2014
Q1 | $3.59M | Sell |
314,202
-27,500
| -8% | -$326K | 0.06% | 144 |
|
|
2013
Q4 | $2.56M | Buy |
341,702
+166,702
| +95% | +$1.14M | 0.04% | 153 |
|
|
2013
Q3 | $857K | Buy |
175,000
+10,000
| +6% | +$56.9K | 0.01% | 218 |
|
|
2013
Q2 | $1.12M | Buy |
+165,000
| New | +$1.23M | 0.02% | 206 |
|
Other funds holding BIOA
Levin Capital Strategies's BIOA Position: Q2 2019 in Review
Levin Capital Strategies sold out of BioAmber Inc. (BIOA) in Q2 2019, closing a stake of 11,200 shares.
Levin Capital Strategies first reported a position in BIOA in Q2 2013 and held it in 24 quarters. The position peaked at $3.59M in Q1 2014. 1 fund tracked by Wall St. Rank holds BIOA as of Q2 2019.
- Levin Capital Strategies reported no remaining BioAmber Inc. position as of Q2 2019 after selling out during the quarter.
- Levin Capital Strategies sold 11,200 BioAmber Inc. shares in Q2 2019.
- Levin Capital Strategies first reported a position in BioAmber Inc. in Q2 2013 and held it in 24 quarters.
- Levin Capital Strategies's BioAmber Inc. position peaked at $3.59M in Q1 2014.
- 1 fund tracked by Wall St. Rank held BioAmber Inc. as of Q2 2019.
Based on Levin Capital Strategies's 13F filing for Q2 2019, filed 13 Aug 2019.